We are delighted to share the release of a special report on in Stockhead today.

Featured in the Health & Biotech section, "‘Diagnose on the spot’: Optiscan’s platform brings together surgeons and pathologists for better cancer outcomes" delves into our pioneering mission to establish a new standard of care in digital pathology and precision surgery, the market potential of our technology, even greater opportunity to improve healthcare efficiencies, and additional context on our pursuit of FDA De Novo clearance for InVivage.


Read the article here